Company Filing History:
8 out of 183 
2 out of 168 
Years Active: 2012-2019
Title: Innovations of Sergey Paushkin in Spinal Muscular Atrophy Treatment
Introduction
Sergey Paushkin is a notable inventor based in Belle Mead, NJ (US), recognized for his contributions to the field of biomedical research. He holds a total of 8 patents, primarily focused on developing compounds for treating spinal muscular atrophy (SMA). His work has significant implications for patients suffering from this debilitating condition.
Latest Patents
Among his latest patents, Paushkin has developed compounds and compositions aimed at treating spinal muscular atrophy. These compounds are designed to modulate the inclusion of exon 7 of the SMN2 gene into mRNA, which is crucial for the production of the SMN protein. Additionally, he has created compounds that can influence the inclusion of exon 7 of the SMN1 gene into mRNA. His innovative approach addresses the genetic underpinnings of SMA, offering potential therapeutic avenues for affected individuals.
Career Highlights
Throughout his career, Paushkin has worked with prominent companies in the pharmaceutical industry, including PTC Therapeutics, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Nikolai A. Naryshkin and Ellen Welch, who have played significant roles in advancing the research and development of SMA treatments alongside Paushkin.
Conclusion
Sergey Paushkin's innovative work in developing compounds for spinal muscular atrophy treatment highlights his commitment to improving patient outcomes. His contributions to the field are paving the way for new therapeutic strategies that could change the lives of many individuals affected by this condition.